Anthem Biosciences Ltd.

“Anthem Biosciences is a structurally differentiated fermentation CRDMO with best-in-class Indian margins, a promoter-aligned founding team, and a long organic reinvestment runway in a China+1-driven outsourcing boom — but trades at 96x trailing earnings with TTM revenue declining 15% and earnings declining 26%, creating a dangerous mismatch between priced-in perfection and visible execution softness. The business deserves a position in a long-term portfolio; the current price does not deserve capital. Monitor for a 30-40% rerating or evidence of re-accelerating growth before initiating.”